LYMPHAGEN, INC.
Modulating lymphatic regeneration to improve human disease
Welcome. We’re Lymphagen, Inc., and we’re disrupting the industry with our groundbreaking solutions and business ideas. Our patent pending technology has already been recognized by market leaders and our scalable business model is setting the trend for industry standards. Curious to find out more? Browse through our website, and get in touch if you would like to request more information.
WHO WE ARE
Lymphagen, Inc. is a leading provider of cutting-edge technologies and services, offering scalable solutions for businesses of all sizes. Founded in 2020 by a USC Professors Young-Kwong Hong, PhD and Alex Wong, MD, we are an early stage biotechnology startup company that aims to modulate lymphangiogenesis after surgical injury as well as for a host of disease processes. Get in touch today to learn more.
OUR TECHNOLOGY
Smart solutions are at the core of all that we do at Lymphagen, Inc.. Our main goal is finding smart ways of using technology that will help build a better tomorrow for everyone, everywhere. Click below to learn more about the technology behind our Biotechnology Startup, or get in touch to set up a meeting with one of our representatives.
"Big results require big ambitions"
